The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Filter
Locations
Result types
Type of company
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Lock keywords
Exclude keywords
Optional keywords
San Jose, United States
1-10 Employees
2017
We provide top-notch, dependable human and non-human primate cells at competitive rates. Our unwavering mission is to empower the scientific community dedicated to biotech research, drug discovery, and therapeutic development. Our core values revolve around swift turnaround times and unwavering product quality, forming the foundation of our service.
+
Featured
Human Cord Blood Plasma
... Cord blood is rich in hematopoietic stem / progenitor cells while it contains all the usual components of blood (red blood cells, platelets, white blood cells, and plasma). HumanCells offers ...
Beaumont, United States
1-10 Employees
Locally owned and operated in Beaumont, Texas, Blood and Plasma Research, Inc.
+
Featured
Home | Blood and Plasma Research, Inc.
... Home | Blood and Plasma Research, Inc. ...
+
Featured
CytoTherm Plasma Thawers
... Manufacturers of Blood Plasma Thawers and Plasma Defrosters for use in Blood Banks and Hospital Labs. ...
Beverly, United States
11-50 Employees
1991
Our mission is to significantly reduce the number of preventable deaths caused by bleeding. We are driven by a team of highly qualified experts. Originally, trading as ZymeQuest, Velico initially explored the development of a universally transfusable blood. Velico began researching a Spray Dried Plasma process based on a government promoted programme for dried plasma. Velico plans to pursue CE (EU) applications to satisfy The European Medical Device Regulation (MDR). Velico is a private, clinical stage medical technology company headquartered in Beverly, Massachusetts, committed to the mission of reducing preventable death from bleeding. We are developing a novel, dry plasma manufacturing system which will equip blood centers around the world to produce point of care, dry plasma products for transfusion. Our investment in talented people, intentional collaborations, innovative engineering and novel technology developments will yield products which will improve access to blood and save countless lives around the world upon release of our first product, FrontlineODP™.
+
Featured
About Velico | Developing Innovative Blood and Plasma Products
... Velico has been focused on developing innovative blood and plasma products for transfusion for over 20 years. Learn more about our mission and products. ...
Stafford, United States
11-50 Employees
2001
Our vision is to build an effective bridge between our manufacturers that we proudly represent and the needs of our valued customers. Our goal is simple – use our experience and training to offer our clients an exceptional product at an exceptional value. Biomedical Solutions Inc (BSI) is a leading manufacturer’s representative of laboratory equipment based in Stafford, Texas, just outside of Houston. From the early stages of design to the commissioning of a new laboratory, BSI is there every step of the way. We offer a variety of high quality laboratory refrigerators, freezers and accessories that are available at competitive prices online. With our trained and experienced staff, we are committed to offering you the highest quality and service when it comes to scientific instrumentation. BioSafety Cabinets & Containment Enclosures offer a wide range of…. Cold Storage Equipment for Laboratory & Clinical research provide the….
+
Featured
HemoRoam 60 Mobile Blood & Plasma Refrigeration | 2.8 cu. ft.
... HemoRoam 60 Mobile Blood & Plasma Refrigeration | 2.8 cu. ft. - The HemoRoam line of mobile, battery-powered refrigerators enables healthcare providers to store blood between 2°C to 8°C and platelets at ...
Gray, United States
1-10 Employees
2009
Biological Specialty Company (BSC) is a leading provider of human blood products and biological specimens to the research community. We offer many ways for you to donate.
+
Featured
Blood & Plasma Donation, Get Compensated
... Donate your blood and plasma to research for the prevention or treatment of diseases. Donors are compensated in appreciation for time and efforts. ...
Haarlem, Netherlands
1-10 Employees
Plasmabiotech is a biotech company with an innovative vision and dedication to developing new products in the field of regenerative medicine. We are the developer, manufacturer, and distributor of patented Swiss Plasma Biotech (SPB) PRP products for autologous blood plasma therapy. The company is leading a paradigm shift in autologous plasma therapies. With expertise, care and persistence, we aim to be a leading provider of autologous plasma therapy products. We focus on providing a comprehensive, future-oriented service, to provide a foundation for long-term business relations. Our PRP Product is certificated in accordance EN ISO 13485, Class IIa a medical device in line with the Directive 93/42/EEC and subsequent(which means that the plasma obtained using them can be injected immediately after centrifugation into the body) and manufactured according to GMP standards. By taking a small volume of your blood and then extracting the platelets, we are able to create a high concentration of these valuable substances which can then be re-injected into areas where they are needed. It is a well-tried naturopathic principle, on which the autologous blood therapy is based: A small amount of up to 10 ml of blood is taken from the arm vein of the patient, can be prepared and/or enriched, and then injected again, usually intramuscularly.
+
Featured
Plasmabiotech NL - About Us
... We are the developer, manufacturer, and distributor of patented Swiss Plasma Biotech (SPB) PRP products for autologous blood plasma therapy. The company ...
Springdale, United States
11-50 Employees
2013
SPRINGDALE, Ark., – March 14, 2024 – NOWDiagnostics (NOWDx) today announced the appointment of Jody Douglas Berry, Ph.D. Springdale, AR, October 18, 2023 – NOWDiagnostics (NOWDx) announces Todd Grice as the World-wide Vice President of Sales. Todd is a proven executive sales leader with over 30 years of experience in the diagnostics industry.
+
Featured
hCG Test – NOWDx
... an immunoassay used for the qualitative detection of human chorionic gonadotropin in human whole blood, plasma, or serum and is indicated as an aid for healthcare professionals in the diagnosis of early pregnancy. Faster, lab accurate results Convenient bedside test Earlier detection ...
Munich, Germany
51-100 Employees
1982
RECIPE is one of the leading CE-IVD providers in LC-MS/MS and HPLC clinical diagnostics. We are committed to meet the needs in your clinical laboratories. Our vision to continuously develop and improve in-vitro diagnostic products and services provided to our valued customers shall ultimately ensure the medical responsability, value for patients and the requirements of a modern laboratory. RECIPE gehört zu den weltweit führenden Unternehmen für die Spezialdiagnostik mit HPLC- und LC-MS/MS Systemen. RECIPE’s focus is the TDM Kit System which is available in drug-specific and rapidly expanding add-on-Sets and automated solutions which are compatible with open LC-MS/MS systems. Since more than 40 years our premium quality products are designed, developed and manufactured in our facilities in Munich. A close relationship with university and research laboratories is a key pillar for developing market-specific HPLC and LC-MS/MS applications. Our product portfolio meets the requests of increasing effectiveness and safety in medical and hospital laboratories.
+
Featured
Vitamins B1, B2 in Whole Blood and Vitamin B6 in Plasma / Whole Blood
... B6 in Plasma / Whole Blood This new kit provides the combined measurement of the vitamins B1, B2 in Whole Blood and B6 Plasma / Whole Blood. Serum Urine Plasma Whole Blood Dried Blood Spots manual sample preparation manual sample preparation ...
United Kingdom
1-10 Employees
2007
At LABMODE Ltd we appreciate and understand the expense, time and dedication needed to turn your scientific ideas and goals into reality. LABMODE offer the next step in the process…how to safely store those critical samples in the correct environment with the systems needed to ensure sample safety, security and viability. LABMODE’s highly innovative and energy efficient range of Sample Storage Solutions will cover every requirement for your laboratory, including: +4°C, -20°C and -80°C Refrigeration units, new concept Nordic -80°C Freezer Systems, and phasetwo Cryogenics Storage Systems for liquid nitrogen storage down to – 196°C. LABMODE’s laboratory Inventory Control Systems are completely bespoke and customisable. The LABMODE portfolio of +4°C, -20°C and -80°C Refrigeration units, Vapour Phase Cryogenics Vessels and Nordic – 80°C Freezer Systems can provide incredible savings by potentially reducing your energy bills, liquid nitrogen consumption and ongoing service costs. LABMODE Ltd were established in April 2007 and are a specialist UK laboratory equipment provider offering the latest range of laboratory equipment to facilities across the UK. LABMODE offer a complete range of refrigeration products. Nordic ULT Freezers LABMODE offer this unique design-and-build solution for storing large numbers of samples at Ultra Low Temperatures.
+
Featured
Blood/Plasma Bag Cassettes
... Blood/Plasma Bag Cassettes - ...
Technologies which have been searched by others and may be interesting for you:
Some interesting numbers and facts about the results you have just received for Blood Plasma
| Country with most fitting companies | United States |
| Amount of fitting manufacturers | 177 |
| Amount of suitable service providers | 102 |
| Average amount of employees | 1-10 |
| Oldest suiting company | 1971 |
| Youngest suiting company | 2017 |
20%
40%
60%
80%
Blood plasma constitutes the liquid component of blood, in which blood cells and platelets are suspended, making up approximately 55% of the body's total blood volume. It is a straw-colored, water-based fluid that is rich in proteins, such as albumin, globulins, and fibrinogen, which play crucial roles in clotting, immune functions, and the maintenance of osmotic balance. Plasma serves as a transport medium for glucose, hormones, metabolic waste products, and carbon dioxide. It is distinguished from serum, which is plasma from which clotting factors have been removed. The composition of blood plasma includes 92% water, with the remaining 8% consisting of plasma proteins, salts, lipids, glucose, amino acids, vitamins, and hormones. Blood plasma's significance within the biomedical field is multifaceted: it is used in the treatment of various conditions including burns, shock, and other blood loss scenarios, where it replenishes fluid volume and maintains adequate blood pressure. Furthermore, plasma derivatives, such as immunoglobulins, clotting factors, and albumin, are critical for patients with immune deficiencies, hemophilia, and other protein deficiencies. The ability to fractionate plasma has led to the development of therapies that are specific to particular diseases, making plasma an essential component not only in clinical medicine but also in the research and development of new treatments.
1. Rich Source of Essential Proteins
: Blood plasma is incredibly rich in essential proteins necessary for clotting and fighting infections. Unlike synthetic alternatives, plasma provides a complex mixture of these proteins that can be crucial for patients with conditions like hemophilia or immune system disorders, offering a more tailored and effective treatment.
2. Speeds Up Recovery
: Plasma transfusions can significantly speed up the recovery process for patients who have lost a lot of blood due to surgery or trauma. It replenishes the volume and maintains the balance of electrolytes, helping the body to stabilize more quickly than synthetic substitutes might allow.
3. Supports Immune System
: Plasma contains antibodies that are critical for fighting off infections. For people with weakened immune systems, plasma transfusions can provide a much-needed boost to help combat diseases or in situations where vaccines are less effective.
4. Lower Risk of Rejection
: Given that blood plasma can be matched to the recipient's blood type, the risk of rejection is significantly lower compared to some synthetic alternatives. This compatibility reduces the risk of complications, making it a safer option for patients needing long-term or repeated treatments.
By leveraging the unique properties of blood plasma, medical professionals can provide treatments that are both efficient and tailored to the specific needs of their patients, offering benefits that synthetic alternatives often cannot match.
While evaluating the different suppliers make sure to check the following criteria:
1. Quality Assurance and Certifications
Ensure the supplier has relevant quality certifications (e.g., ISO 13485, FDA approval for medical devices) and follows strict quality control measures for blood plasma processing.
2. Regulatory Compliance
Verify that the supplier complies with all local and international regulations governing the collection, storage, and distribution of blood plasma.
3. Source and Traceability
The supplier should provide clear documentation of the source of plasma and maintain traceability throughout the supply chain to ensure safety and integrity.
4. Storage and Transportation
Check the supplier's capabilities for proper storage and transportation conditions (e.g., temperature control) to maintain the viability of blood plasma.
5. Supply Capacity and Reliability
Assess the supplier’s ability to consistently meet your demand in terms of volume and delivery timelines, without compromising quality.
6. Technical Support and Customer Service
Evaluate the supplier’s reputation for providing technical support and customer service, including responsiveness to inquiries and post-purchase support.
7. Cost-effectiveness
While quality and safety should not be compromised, compare pricing among suppliers to ensure cost-effectiveness for your specific needs.
Blood plasma plays a crucial role in the pharmaceutical industry, primarily for the production of plasma-derived medicinal products. Companies specializing in biopharmaceuticals harness plasma to develop treatments for a variety of conditions including hemophilia, immune system deficiencies, and other blood-related disorders. This process involves separating plasma from blood and then fractionating it into its component proteins, which are then purified and converted into therapeutic products. This sector heavily relies on a steady supply of plasma to meet the manufacturing needs of these life-saving medications. In the biomedical research field, blood plasma is a valuable resource for scientists and researchers. It serves as a key component in the study of diseases, the development of new drugs, and the testing of medical treatments. Plasma contains antibodies, hormones, and enzymes, making it an indispensable sample for various experimental and analytical purposes. Businesses engaged in biomedical research often purchase plasma from specialized suppliers to support their investigative and development endeavors. The cosmetics industry represents another interesting B2B use case for blood plasma, particularly in the development of high-end skincare products. Companies utilize plasma due to its rich content of growth factors and proteins that are believed to promote skin regeneration and repair. This application leverages the bioactive properties of plasma to formulate products aimed at anti-aging, healing, and rejuvenation. As consumers increasingly seek out natural and scientifically-backed ingredients, the demand for plasma-based cosmetics continues to grow within the beauty sector.
Blood plasma, a critical component of medical therapies, diagnostics, and research, has reached a high Technology Readiness Level (TRL), specifically TRL 9. This status indicates that blood plasma technologies are fully mature, having been successfully validated in real-world conditions. The journey to this advanced TRL stems from decades of rigorous clinical trials, technological advancements in plasma collection, processing, and storage, as well as the establishment of stringent safety and quality standards globally. Technical reasons underpinning its placement at TRL 9 include the development of sophisticated techniques for separating plasma components, enabling the targeted use of these components in various medical treatments, such as clotting factor deficiencies, immune system disorders, and trauma care. Additionally, advancements in pathogen reduction technologies and the implementation of robust donor screening processes have significantly minimized the risk of transfusion-transmitted infections, enhancing the safety and reliability of plasma-derived products. Furthermore, the establishment of a comprehensive regulatory framework overseeing plasma collection, processing, and distribution has played a pivotal role in ensuring the consistent quality and efficacy of plasma products, solidifying their status at the highest TRL.
In the short-term, advancements in blood plasma technology are expected to focus on improving the efficiency and safety of plasma collection and processing. New technologies like portable plasma collection devices and automated systems are being developed to reduce contamination risks and increase the yield of plasma from donations. Additionally, there is a push towards enhancing plasma fractionation techniques to isolate specific proteins more efficiently, leading to better-quality therapeutic products. Mid-term developments are likely to revolve around the expansion of plasma-derived therapies. With the advent of more sophisticated genetic engineering and biotechnology methods, the next few years will see an increase in targeted therapies for a variety of conditions, from immune disorders to rare diseases. This period will also witness the integration of artificial intelligence and machine learning in predicting plasma donation trends and in optimizing plasma product distribution, thereby ensuring better management of plasma resources. Looking into the long-term, the horizon is set for revolutionary changes with the potential introduction of synthetic or lab-grown plasma. This innovation aims to address the limitations of donor-dependent plasma supply and to eliminate the risk of transfusion-transmitted infections. Furthermore, advancements in regenerative medicine may enable the development of personalized plasma products, tailored to the specific needs of individual patients, enhancing the efficacy of treatments and minimizing adverse reactions. These futuristic strides will redefine the landscape of plasma medicine, making it more sustainable, safe, and patient-centric.
Some interesting questions that has been asked about the results you have just received for Blood Plasma
What are related technologies to Blood Plasma?
Based on our calculations related technologies to Blood Plasma are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Which industries are mostly working on Blood Plasma?
The most represented industries which are working in Blood Plasma are Health Care, Biotechnology, Commerce and Shopping, Manufacturing, Others
How does ensun find these Blood Plasma Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.
